141 related articles for article (PubMed ID: 33644844)
1. Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography.
Shou Y; Yang L; Yang Y; Zhu X; Li F; Yin B; Zheng Y; Xu J
Front Med; 2021 Aug; 15(4):585-593. PubMed ID: 33644844
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
[TBL] [Abstract][Full Text] [Related]
3. Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.
Suo H; Jiang B; Sun X; Dong J; Alamgir M; Guan X; Su H; Liu Y; Xia Y; Zhou N; Feng A; Tao J
Dermatology; 2022; 238(4):736-744. PubMed ID: 34875648
[TBL] [Abstract][Full Text] [Related]
4. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Duplisea MJ; Roberson ML; Chrisco L; Strassle PD; Williams FN; Ziemer CM
J Am Acad Dermatol; 2021 Oct; 85(4):873-877. PubMed ID: 33940101
[TBL] [Abstract][Full Text] [Related]
5. Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis.
Koh HK; Fook-Chong S; Lee HY
JAMA Dermatol; 2020 Dec; 156(12):1294-1299. PubMed ID: 33084873
[TBL] [Abstract][Full Text] [Related]
6. RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Zhang L; Lan Y; Qi B; Shuai P; Hou Q; Liu W; Wang Q
Allergy Asthma Immunol Res; 2023 Nov; 15(6):812-824. PubMed ID: 37957797
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.
Sekula P; Liss Y; Davidovici B; Dunant A; Roujeau JC; Kardaun S; Naldi L; Schumacher M; Mockenhaupt M
J Burn Care Res; 2011; 32(2):237-45. PubMed ID: 21228709
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
Torres-Navarro I; Briz-Redón Á; Botella-Casas G; Sahuquillo-Torralba A; Calle-Andrino A; de Unamuno-Bustos B; Piqueras-García J; Roca Ginés J; Magdaleno Tapial J; Alegre de Miquel V; Botella-Estrada R
J Dermatol; 2020 Oct; 47(10):1182-1186. PubMed ID: 32856355
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
[TBL] [Abstract][Full Text] [Related]
10. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.
Bansal S; Garg VK; Sardana K; Sarkar R
Int J Dermatol; 2015 Jan; 54(1):e18-26. PubMed ID: 25534407
[TBL] [Abstract][Full Text] [Related]
11. Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis: The Role of Novel Inflammatory Markers and Proposed Revision of SCORTEN (Re-SCORTEN).
Koh HK; Fook-Chong SMC; Lee HY
JAMA Dermatol; 2022 Feb; 158(2):160-166. PubMed ID: 34935871
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhang Z; Yu K; Jiang Z; Liu O; Wan C; Wu H; Cao X
J Dermatol; 2023 Apr; 50(4):518-524. PubMed ID: 36478458
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
14. Antishear Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Follow-up Study.
Haravu PN; Gottlieb LJ; Vrouwe SQ
J Burn Care Res; 2021 Nov; 42(6):1152-1161. PubMed ID: 34370855
[TBL] [Abstract][Full Text] [Related]
15. How Does SCORTEN Score?
Zavala S; O'Mahony M; Joyce C; Baldea AJ
J Burn Care Res; 2018 Jun; 39(4):555-561. PubMed ID: 29789855
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
[TBL] [Abstract][Full Text] [Related]
17. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.
Cartotto R; Mayich M; Nickerson D; Gomez M
J Burn Care Res; 2008; 29(1):141-6. PubMed ID: 18182912
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China.
Zhu QY; Ma L; Luo XQ; Huang HY
J Burn Care Res; 2012; 33(6):e295-308. PubMed ID: 22955159
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis.
Torres-Navarro I; Briz-Redón Á; Botella-Estrada R
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2066-2077. PubMed ID: 31912590
[TBL] [Abstract][Full Text] [Related]
20. An alternative model for assessing mortality risk in Stevens Johnson syndrome/toxic epidermal necrolysis using a random forests classifier: A pilot study.
Shareef O; Kwan JT; Lau S; Tahboub MA; Saeed HN
Front Med (Lausanne); 2022; 9():935408. PubMed ID: 36569158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
